Radislav Sedlacek participated in the panel discussion at EU-AMRI launch event

14. 04. 2022 News PR

“Research infrastructures are perfectly positioned to co-work at the frontier of science and industry.”, said Radislav Sedlacek, Director of the Czech Centre for Phenogenomics and the former Chair of the ESFRI Health and Food Strategic Working Group at the EU-AMRI launch event, which took place on 5th April 2022 in Brussels. You can watch the…


13. 04. 2022 Event

8-10 May 2022, Seoul, Republic of Korea / Insights into the gene function that IMPC and INFRAFRONTIER have consistently explored through mouse models play a crucial role in advancing biomedical science. The meeting will bring together IMPC and INFRAFRONTIER delegates across the globe, as well as domestic experts from academia, research institutes, industries and the…

Вакансії для біженців з України

18. 03. 2022 Information Jobs

Czech Centre for Phenogenomics пропонує науковцям та лаборантам з України можливість займатися дослідницькою діяльністю в нашому центрі. Ми також вітаємо тих, хто зацікавлений у посаді лаборанта з догляду за лабораторними тваринами для якої не потрібно мати наукову освіту. Для отримання більш детальної інформації, будь ласка, відвідайте сторінку вакансій на нашому веб-сайті.

EU-AMRI Launch Event

14. 03. 2022 Event

5 April 2022, online / EU-AMRI, the European Alliance of Medical Research Infrastructures, is the collaboration between the European research infrastructures BBMRI-ERIC, EATRIS-ERIC, and ECRIN-ERIC. Radislav Sedlacek from CCP, former Chair of the ESFRI Health and Food Strategic Working Group, will participate in the roundtable discussion. Registration is free of charge. More information: EU-AMRI website.

Towards precision medicine and gene therapy – a new AV21 Strategy programme

01. 03. 2022 Information News PR

Czech Centre for Phenogenomics is coordinating a new research programme “Towards precision medicine and gene therapy” of the AV21 Strategy. Our programme benefits from the synergistic expertise of all partners and creates a multidisciplinary consortium covering the areas of gene editing, organic chemistry of nucleic acid delivery systems, preclinical models of human diseases, and starting with neurosciences…

Mice and genetic scissors help Czech scientists seek treatment for “angelic” children

28. 02. 2022 Information News

On the occasion of the International Day of Rare Diseases Czech Centre for Phenogenomics in collaboration with BIOCEV and Czech Academy of Sciences issued a press release summarizing their research in the area of rare diseases. The press release (in English) is available on the BIOCEV website. The press release (in Czech) is available on…

Mouse models from the Czech Centre for Phenogenomics help in researching Angelman’s syndrome

14. 02. 2022 Information News

We are celebrating the International Angelman Day on 15th February. Angelman’s syndrome is an inherited disease of the central nervous system that causes severe physical and mental disabilities. The team of the Czech Center for Phenogenomics is engaged in research of Angelman’s syndrome (and other rare diseases) on mouse models created by us or already…

Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern

07. 02. 2022 News Publication

The emergence of new SARS-CoV-2 variants that harbor mutations in the viral S protein raised concern about activity of current vaccines and therapeutic antibodies. CCP participated in the research study aiming to find new tools for COVID-19 therapy based on the novel monoclonal antibodies. The results were recently published in EBioMedicine belonging to the Lancet…

Czech-Swiss project “SARS-Cov-2: understanding the entry, multi-organ spread and immune response in the context of vaccination and re-infection” received funding.

28. 01. 2022 Information News

Our collaboration with Luca Varani’s lab from the Institute for Research in Biomedicine in Bellinzona in Switzerland will expand thanks to the grants of the Czech and the Swiss Science Foundations. Both foundations decided to fund our joint project “SARS-Cov-2: understanding the entry, multi-organ spread and immune response in the context of vaccination and re-infection”…